38 related articles for article (PubMed ID: 8290272)
1. Establishment and validation of a novel integrin-based prognostic gene signature that sub-classifies gliomas and effectively predicts immunosuppressive microenvironment.
Qi C; Lei L; Hu J; Ou S
Cell Cycle; 2023 May; 22(10):1259-1283. PubMed ID: 37096960
[TBL] [Abstract][Full Text] [Related]
2. Identification of key biomarkers associated with cell adhesion in multiple myeloma by integrated bioinformatics analysis.
Peng Y; Wu D; Li F; Zhang P; Feng Y; He A
Cancer Cell Int; 2020; 20():262. PubMed ID: 32581652
[TBL] [Abstract][Full Text] [Related]
3. Integrin
Zhang YL; Xing X; Cai LB; Zhu L; Yang XM; Wang YH; Yang Q; Nie HZ; Zhang ZG; Li J; Zhang XL
J Immunol Res; 2018; 2018():4602570. PubMed ID: 29951557
[TBL] [Abstract][Full Text] [Related]
4. Expression level and methylation status of three tumor suppressor genes, DLEC1, ITGA9 and MLH1, in non-small cell lung cancer.
Pastuszak-Lewandoska D; Kordiak J; Antczak A; Migdalska-Sęk M; Czarnecka KH; Górski P; Nawrot E; Kiszałkiewicz JM; Domańska-Senderowska D; Brzeziańska-Lasota E
Med Oncol; 2016 Jul; 33(7):75. PubMed ID: 27287342
[TBL] [Abstract][Full Text] [Related]
5. Integrin α9 gene promoter is hypermethylated and downregulated in nasopharyngeal carcinoma.
Nawaz I; Hu LF; Du ZM; Moumad K; Ignatyev I; Pavlova TV; Kashuba V; Almgren M; Zabarovsky ER; Ernberg I
Oncotarget; 2015 Oct; 6(31):31493-507. PubMed ID: 26372814
[TBL] [Abstract][Full Text] [Related]
6. Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition.
Gupta SK; Oommen S; Aubry MC; Williams BP; Vlahakis NE
Oncogene; 2013 Jan; 32(2):141-50. PubMed ID: 22370635
[TBL] [Abstract][Full Text] [Related]
7. External Qi of Yan Xin Qigong induces cell death and gene expression alterations promoting apoptosis and inhibiting proliferation, migration and glucose metabolism in small-cell lung cancer cells.
Yan X; Li F; Dozmorov I; Frank MB; Dao M; Centola M; Cao W; Hu D
Mol Cell Biochem; 2012 Apr; 363(1-2):245-55. PubMed ID: 22160803
[TBL] [Abstract][Full Text] [Related]
8. Integrin alpha9 (ITGA9) expression and epigenetic silencing in human breast tumors.
Mostovich LA; Prudnikova TY; Kondratov AG; Loginova D; Vavilov PV; Rykova VI; Sidorov SV; Pavlova TV; Kashuba VI; Zabarovsky ER; Grigorieva EV
Cell Adh Migr; 2011; 5(5):395-401. PubMed ID: 21975548
[TBL] [Abstract][Full Text] [Related]
9. Integrin α9β1-mediated cell migration in glioblastoma via SSAT and Kir4.2 potassium channel pathway.
Veeravalli KK; Ponnala S; Chetty C; Tsung AJ; Gujrati M; Rao JS
Cell Signal; 2012 Jan; 24(1):272-81. PubMed ID: 21946432
[TBL] [Abstract][Full Text] [Related]
10. Integrin alpha9beta1: Unique signaling pathways reveal diverse biological roles.
Gupta SK; Vlahakis NE
Cell Adh Migr; 2010; 4(2):194-8. PubMed ID: 20179422
[TBL] [Abstract][Full Text] [Related]
11. PGP9.5 as a candidate tumor marker for non-small-cell lung cancer.
Hibi K; Westra WH; Borges M; Goodman S; Sidransky D; Jen J
Am J Pathol; 1999 Sep; 155(3):711-5. PubMed ID: 10487828
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of a Myc antagonist, ROX/Mnt, at 17p13.3 in human lung cancers.
Takahashi T; Konishi H; Kozaki K; Osada H; Saji S; Takahashi T; Takahashi T
Jpn J Cancer Res; 1998 Apr; 89(4):347-51. PubMed ID: 9617337
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of the FHIT gene in colorectal cancers.
Hibi K; Taguchi M; Nakamura H; Hirai A; Fujikake Y; Matsui T; Kasai Y; Akiyama S; Ito K; Takagi H
Jpn J Cancer Res; 1997 Apr; 88(4):385-8. PubMed ID: 9197530
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 variant isoforms in normal and neoplastic cells of the lung.
Washimi O; Ueda R; Ariyoshi Y; Suyama M; Seki T; Takahashi T; Takahashi T
Jpn J Cancer Res; 1994 Nov; 85(11):1112-6. PubMed ID: 7530240
[TBL] [Abstract][Full Text] [Related]
15. Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer.
Hibi K; Yamakawa K; Ueda R; Horio Y; Murata Y; Tamari M; Uchida K; Takahashi T; Nakamura Y; Takahashi T
Oncogene; 1994 Feb; 9(2):611-9. PubMed ID: 8290272
[TBL] [Abstract][Full Text] [Related]
16. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
17. Distinct 3p21.3 deletions in lung cancer and identification of a new human semaphorin.
Roche J; Boldog F; Robinson M; Robinson L; Varella-Garcia M; Swanton M; Waggoner B; Fishel R; Franklin W; Gemmill R; Drabkin H
Oncogene; 1996 Mar; 12(6):1289-97. PubMed ID: 8649831
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of deletions in human chromosome 3p21 and the role of resident cancer genes in disease.
Angeloni D
Brief Funct Genomic Proteomic; 2007 Mar; 6(1):19-39. PubMed ID: 17525073
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
